BioCeramic Therapeutics appoints Ian Brown
January 27, 2010Research and Development BioCeramic Therapeutics, appointment, research and development
BioCeramic Therapeutics has appointed Ian Brown chief executive, taking over from Daniel Green who will remain on the board as …
In brief: European Medicines Agency news
January 26, 2010Research and Development, Sales and Marketing Arepanrix, Arzerra, EMEA, GSK, Tysabri
GlaxoSmithKline’s influenza vaccine Arepanrix has been granted conditional marketing authorisation in Europe under an emergency fast-track procedure.It is the fourth …
Quintiles re-positions itself for changing biopharma industry
January 26, 2010Research and Development, Sales and Marketing CRO, Quintiles
Leading services company Quintiles has unveiled a new corporate identity to help showcase the diversity of its business.The company, best …
Digital Pharma – Online patient recruitment drive for GSK’s anxiety drug
January 26, 2010Research and Development GlaxoSmithKline, PTSD, digital research, orvepitant, patient recruitment
GlaxoSmithKline is readying to move its post-traumatics stress disorder candidate orvepitant into phase II trials, a move being supported by …
New ways of measuring sales performance needed
January 26, 2010Business Services, Sales and Marketing sales force effectiveness, training
Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …
Huge drug discovery database launched
January 26, 2010Research and Development ChEMBLdb, Wellcome, genome, genomics
A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …
Merck appoints UK leadership team
January 26, 2010MSD, Merck & Co, appointment
Merck & Co’s UK business has unveiled its new leadership team, following last year’s merger with Schering-Plough. Merck Sharp & …
National clinical directors appointed
January 26, 2010NHS, UK, appointment, dementia, elderly, liver disease
A trio of national clinical directors, whose areas of influence cover dementia, older people and liver disease, have been appointed …
Roche invests in production of new Herceptin formulation
January 25, 2010Manufacturing and Production, Research and Development Herceptin, Roche
Roche will spend 190 million Swiss francs ($183m) to put production capacity in place for a new self-administered formulation of …
Niche pharma company HRA expands into Spain
January 25, 2010Sales and Marketing HRA Pharma, Spain
French reproductive health and endocrinology company HRA Pharma has set up commercial operations in Spain, its fifth European base to …
PPD lists market recovery and more acquisitions in 2010 forecasts
January 25, 2010Research and Development CRO, Caprion Proteomics, PPD
Pharmaceutical Product Development (PPD) expects revenues in 2010 to grow around 6% as the high rate of project cancellations in …
Manufacturing news in brief
January 25, 2010Manufacturing and Production Elona Biotech, Genzyme, Lupin, Patheon, State Pharmaceuticals Manufacturing, SurModics
Our round-up of developments in pharmaceutical manufacturing includes a new contract between Patheon and Sanofi-Aventis, hiring plans at Genzyme and …
Abbott’s weight-loss drug suspended in Europe
January 25, 2010Sales and Marketing Abbott, Reductil
Doctors have been told not to prescribe Abbott’s weight-loss treatment sibutramine after a safety review found evidence of serious cardiovascular …
Clavis Pharma appoints Olav Hellebø
January 25, 2010Research and Development, Sales and Marketing Clavis Pharma, appointment, research and development, sales and marketing
Norwegian cancer drug development company Clavis Pharma has appointed Olav Hellebø as its new chief executive. He joins the company …
2010 and beyond
January 25, 2010Sales and Marketing em, emerging markets, industry
The global pharma market is expected to grow between 4 to 6% on a constant dollar basis and is expected …
Patient access scheme secures NICE approval for Cimzia
January 22, 2010Sales and Marketing Cimzia, NICE, UCB, rheumatoid arthritis
UCB Pharma’s Cimzia has been recommended by NICE to treat rheumatoid arthritis – but only if a patient access scheme …
Digital Pharma – Byte-sized roundup
January 22, 2010Medical Communications Fresenius Kabi, P&G, Prilosec OTC, Seroquel, Twitter, digital pharma
In this week’s roundup: P&G taps social media for Prilosec OTC, UK launches new data site, analysis of pharma on …
Tudor Reilly opens first London office
January 22, 2010Medical Communications Tudor Reilly
Beaconsfield-based healthcare PR agency Tudor Reilly has opened its a second office in Baker Street, London.The healthcare communications consultancy, which is …
Russia’s health drive to help pharma growth
January 22, 2010Sales and Marketing Russia, em, emerging markets, industry
Russia endured a turbulent 2009 in economic terms, thanks to the steep drop in oil prices, but the country is …
PDS appoints Graham Clapperton
January 22, 2010Research and Development PDS, appointment, research and development
Pharmaceutical Development Services Ltd (PDS) has appointed Graham Clapperton to head up its quality services. Graham joins the Nottingham, UK-based consultancy …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
